MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

NAMS NewAmsterdam Pharma Company NV Forecast, Technical & Fundamental Analysis

Industry Biotechnology
NAMS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For NAMS
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NAMS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For NAMS
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

NAMS is expected to report earnings to rise 164.56% to -47 cents per share on March 28

NewAmsterdam Pharma Company NV NAMS Stock Earnings Reports
Q4'24
Est.
$-0.48
Q3'24
Beat
by $0.32
Q2'24
Beat
by $0.17
Q1'24
Missed
by $0.44
Q4'23
Beat
by $0.04
The last earnings report on November 06 showed earnings per share of -18 cents, beating the estimate of -49 cents. With 836.66K shares outstanding, the current market capitalization sits at 2.31B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSIHX21.57N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps A
FUGIX47.56-0.23
-0.48%
Fidelity Advisor Utilities I
NMSAX26.31-0.34
-1.28%
Columbia Small Cap Index A
ZVGIX50.33-0.79
-1.55%
Zevenbergen Genea Institutional
KINCX78.02-1.51
-1.90%
Kinetics Internet Adv C

NAMS and Stocks

Correlation & Price change

A.I.dvisor tells us that NAMS and GYRE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NAMS and GYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
-0.61%
GYRE - NAMS
32%
Poorly correlated
-9.56%
SANA - NAMS
25%
Poorly correlated
-6.34%
WXXWY - NAMS
24%
Poorly correlated
-3.37%
SLN - NAMS
24%
Poorly correlated
-5.74%
ANAB - NAMS
23%
Poorly correlated
-3.40%
More